Lupin Pharmaceuticals announced that it has received FDA approval for Norgestimate and Ethinyl Estradiol Tablets, the generic version of Janssen‘s Ortho Tri-Cyclen Lo tablets.
Ortho Tri-Cyclen Lo is a progestin and estrogen combination indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. This combination suppresses ovulation by imitating the feedback inhibition of endogenous estrogen and progesterone on the pituitary and hypothalamus.
Norgestimate and Ethinyl Estradiol Tablets will be available from Lupin in 0.18mg/0.025mg, 0.215mg/0.025mg, and 0.25 mg/0.025 mg dosage strength tablets.
For more information call (866) 587-4617 or visit www.lupinpharmaceuticals.com.